Back
Lonza Group Vs. Dyne Therapeutics Industry Stock Comparison
Buy
56
LZAGF
Lonza Group
Last Price:
550.00
Seasonality Move:
6.22%
Buy
70
DYN
Dyne Therapeutics
Last Price:
35.34
Seasonality Move:
14.48%
Buy
56
Lonza Group (LZAGF)
is a Buy
Is Lonza Group a Buy, Sell or Hold?
- The current Lonza Group [LZAGF] share price is $550.00. The Score for LZAGF is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- LZAGF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
70
Dyne Therapeutics (DYN)
is a Buy
Is Dyne Therapeutics a Buy, Sell or Hold?
- The current Dyne Therapeutics [DYN] share price is $35.34. The Score for DYN is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
- DYN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
LZAGF Stock Price Chart
What is Lonza Group's stock price today?
-
The Lonza Group share price today is $550.00
The current trend is relatively stagnant and LZAGF is experiencing buying pressure, which is a positive indicator for future bullish movement.
DYN Stock Price Chart
What is Dyne Therapeutics's stock price today?
-
The Dyne Therapeutics share price today is $35.34
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DYN is experiencing slight buying pressure.
LZAGF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -4.23 | Sell |
| Relative Strength Index (14 RSI): | 50.04 | Buy |
| Chaikin Money Flow: | 107 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (533.59 - 559.35) | Buy |
| Bollinger Bands (100): | (526.04 - 582.64) | Sell |
DYN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.4 | Buy |
| Relative Strength Index (14 RSI): | 61.32 | Buy |
| Chaikin Money Flow: | 956037 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (31.02 - 34.14) | Buy |
| Bollinger Bands (100): | (24.19 - 31.31) | Buy |
LZAGF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 543.48 | Buy |
| 20-day SMA: | 547.86 | Buy |
| 50-day SMA: | 557.34 | Sell |
| 200-day SMA: | 487.03 | Buy |
| 8-day EMA: | 545.12 | Buy |
| 20-day EMA: | 547.66 | Buy |
| 50-day EMA: | 552.34 | Sell |
| 200-day EMA: | 528.09 | Buy |
DYN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 34.34 | Buy |
| 20-day SMA: | 32.99 | Buy |
| 50-day SMA: | 29.68 | Buy |
| 200-day SMA: | 19.72 | Buy |
| 8-day EMA: | 34.37 | Buy |
| 20-day EMA: | 33.08 | Buy |
| 50-day EMA: | 30.6 | Buy |
| 200-day EMA: | 22.62 | Buy |
Lonza Group Earnings Growth & LZAGF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Dyne Therapeutics Earnings Growth & DYN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.05 per share, an increase this year of $0.77 per share, and an increase next year of $0.16 per share.
Lonza Group Technical Analysis
| Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Dyne Therapeutics Technical Analysis
| Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||